Indraprastha Medical Corporation Limited

Price Chart

Risk-Adjusted Performance

Indraprastha Medical Corporation Limited (INDRAMEDCO) Price Performance

Indraprastha Medical Corporation Limited (INDRAMEDCO) trades on NSE in INR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at INR427.10, up 0.52% from the previous close.

Over the past year, INDRAMEDCO has traded between a low of INR349.50 and a high of INR622.80. The stock has lost 6.6% over this period. It is currently 31.4% below its 52-week high.

Indraprastha Medical Corporation Limited has a market capitalization of $38.95B, with a price-to-earnings ratio of 21.30.

About Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.